NCT05618457View on ClinicalTrials.gov

Adjustment of Aminoglycoside Dosing Based on Peak Serum Concentration and Bacterial Minimal Inhibitory Concentration

NARecruitingINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Aminoglycoside Dosing Based on PK/PD Characteristics
Interventions
DRUG

Aminoglycoside dose adjustment

Eligible patients may have the aminoglycoside dose adjusted based on pathogen MIC, to attain the PK/PD target of Cam/MIC\~10 (8-12)

Trial Locations (1)

12000

RECRUITING

Hadassah Hebrew University Medical Center, Jerusalem

All Listed Sponsors
lead

Hadassah Medical Organization

OTHER